Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

The polyherbal hair gel with guava leaves, amla, and aloe is effective for scalp health and treating fungal infections.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Ruxolitinib can cause a delayed skin reaction on the nose.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Metabolic signals and cell shape influence how cells develop and change.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Clonally expanded CD8+ T cells cause alopecia areata.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Blood metabolites significantly influence alopecia areata risk.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Treating stubborn hair loss involves both medical and emotional support options.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.